More Ammo Against Withdrawn Surgery Drug

By MIKE STOBBE, AP Medical Writer, Medicine & Health / Medications

(AP) -- Heart surgery patients were more likely to die if given the anti-bleeding drug Trasylol, two more U.S. studies have found, renewing the claims that the drug is dangerous. Bayer AG stopped selling the drug last fall, after a Canadian study was halted because of deaths among patients taking Trasylol.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---

» Next Article in Medicine & Health - Medications: More Fentanyl Patches Recalled